Published in Circulation on July 25, 2011
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Healthy lifestyle in the primordial prevention of cardiovascular disease among young women. J Am Coll Cardiol (2015) 1.79
Physical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adults. J Am Coll Cardiol (2012) 1.74
Associations of job strain and lifestyle risk factors with risk of coronary artery disease: a meta-analysis of individual participant data. CMAJ (2013) 1.66
Multiple health behaviours: overview and implications. J Public Health (Oxf) (2012) 1.46
Cardiovascular risk factors one year after a hypertensive disorder of pregnancy. J Womens Health (Larchmt) (2014) 1.40
Healthy lifestyle change and subclinical atherosclerosis in young adults: Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation (2014) 1.34
Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health? Epidemiol Rev (2013) 1.28
Ideal cardiovascular health and mortality: Aerobics Center Longitudinal Study. Mayo Clin Proc (2012) 1.18
The Obesity Epidemic: The United States as a Cautionary Tale for the Rest of the World. Curr Epidemiol Rep (2014) 1.12
Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity. J Physiol (2015) 1.10
Translating personality psychology to help personalize preventive medicine for young adult patients. J Pers Soc Psychol (2014) 1.04
Leading Causes of Death among Asian American Subgroups (2003-2011). PLoS One (2015) 1.01
Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry (2014) 0.99
Lifestyle interventions for hypertension treatment among Iranian women in primary health-care settings: Results of a randomized controlled trial. J Res Med Sci (2015) 0.98
Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. Vasc Health Risk Manag (2013) 0.94
Is blood pressure control for stroke prevention the correct goal? The lost opportunity of preventing hypertension. Stroke (2015) 0.94
Type 2 diabetes mellitus and exercise impairment. Rev Endocr Metab Disord (2013) 0.93
Physical activity opposes coronary vascular dysfunction induced during high fat feeding in mice. J Physiol (2012) 0.92
The rise of cardiovascular medicine. Eur Heart J (2012) 0.92
Lifestyle-based prediction model for the prevention of CVD: the Healthy Heart Score. J Am Heart Assoc (2014) 0.91
Differential changes in vascular mRNA levels between rat iliac and renal arteries produced by cessation of voluntary running. Exp Physiol (2012) 0.90
Importance of engaging obstetrician/gynecologists in cardiovascular disease prevention. Curr Opin Cardiol (2013) 0.90
microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis. Adv Exp Med Biol (2015) 0.89
Impact of nutrition since early life on cardiovascular prevention. Ital J Pediatr (2012) 0.85
Unique transcriptomic signature of omental adipose tissue in Ossabaw swine: a model of childhood obesity. Physiol Genomics (2014) 0.85
Potential clinical translation of juvenile rodent inactivity models to study the onset of childhood obesity. Am J Physiol Regul Integr Comp Physiol (2012) 0.84
Multi-locus candidate gene analyses of lipid levels in a pediatric Turkish cohort: lessons learned on LPL, CETP, LIPC, ABCA1, and SHBG. OMICS (2013) 0.83
Cerebrovascular disease in South Asia - Part II: Risk factors and prevention. JRSM Cardiovasc Dis (2012) 0.82
Elevated uric acid and obesity-related cardiovascular disease risk factors among hypertensive youth. Pediatr Nephrol (2015) 0.82
Aragon workers' health study--design and cohort description. BMC Cardiovasc Disord (2012) 0.82
PCSK9 Inhibitors: A Technology Worth Paying For? Pharmacoeconomics (2016) 0.81
Geographical variation in health-related physical fitness and body composition among Chilean 8th graders: a nationally representative cross-sectional study. PLoS One (2014) 0.81
A Global Perspective on Cardiovascular Disease in Vulnerable Populations. Can J Cardiol (2015) 0.81
Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy. Lipids Health Dis (2016) 0.80
Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool. J Am Coll Cardiol (2016) 0.80
Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on Atherosclerosis. Scientifica (Cairo) (2015) 0.79
Bushehr Elderly Health (BEH) Programme, phase I (cardiovascular system). BMJ Open (2015) 0.79
Paradoxical increase in stroke mortality among Asian Indians in the United States. J Vasc Interv Neurol (2014) 0.79
Type 2 diabetes among Asian Americans: Prevalence and prevention. World J Diabetes (2015) 0.79
Lest we forget: comparing retrospective and prospective assessments of adverse childhood experiences in the prediction of adult health. J Child Psychol Psychiatry (2016) 0.79
Stroke Risk Factors, Genetics, and Prevention. Circ Res (2017) 0.78
NHLBI integrated pediatric guidelines: battle for a future free of cardiovascular disease. Future Cardiol (2013) 0.78
Pediatric lipid management: an earlier approach. Endocrinol Metab Clin North Am (2014) 0.78
Prevalence of dyslipidemia in Iranian children and adolescents: A systematic review. J Res Med Sci (2015) 0.77
Racial Differences in the Incidence of Cardiovascular Risk Factors in Older Black and White Adults. J Am Geriatr Soc (2016) 0.77
Chinese herbal medicine for the treatment of prehypertension. Evid Based Complement Alternat Med (2013) 0.77
Disparities in long-term cardiovascular disease risk by sexual identity: The National Longitudinal Study of Adolescent to Adult Health. Prev Med (2015) 0.77
Predicted long-term cardiovascular risk among young adults in the national longitudinal study of adolescent health. Am J Public Health (2014) 0.77
Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center. Lipids Health Dis (2016) 0.77
Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden. Eur J Health Econ (2015) 0.76
The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application. Int J Mol Sci (2017) 0.75
Racial and ethnic residential segregation and access to health care in rural areas. Health Place (2016) 0.75
Habitual aerobic exercise does not protect against micro- or macrovascular endothelial dysfunction in healthy estrogen-deficient postmenopausal women. J Appl Physiol (1985) (2016) 0.75
Psychiatrists' approach to vascular risk assessment in Latin America. World J Psychiatry (2014) 0.75
The implications of fundamental cause theory for priority setting. Am J Public Health (2014) 0.75
A call to action: responding to the future forecasting of cardiovascular disease in america. Am Health Drug Benefits (2011) 0.75
Staying Young at Heart: Cardiovascular Disease Prevention in Adolescents and Young Adults. Curr Treat Options Cardiovasc Med (2015) 0.75
Development of proprotein convertase subtilisin/kexin type 9 inhibitors and the clinical potential of monoclonal antibodies in the management of lipid disorders. Vasc Health Risk Manag (2016) 0.75
Adolescent Diet Quality and Cardiovascular Disease Risk Factors and Incident Cardiovascular Disease in Middle-Aged Women. J Am Heart Assoc (2016) 0.75
Primordial and primary prevention programs for cardiovascular diseases: from risk assessment through risk communication to risk reduction. A review of the literature. Clinics (Sao Paulo) (2016) 0.75
Kā-HOLO Project: a protocol for a randomized controlled trial of a native cultural dance program for cardiovascular disease prevention in Native Hawaiians. BMC Public Health (2017) 0.75
Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress. Aging (Albany NY) (2017) 0.75
Determinants of Raised Blood Pressure in Urban Uganda: A Community-Based Case-Control Study. Ethn Dis (2017) 0.75
Effects of lifestyle modification programs on cardiac risk factors. PLoS One (2014) 0.75
The Unchartered Frontier: Preventive Cardiology Between the Ages of 15 and 35 Years. Curr Cardiovasc Risk Rep (2016) 0.75
High level of depressive symptoms as a barrier to reach an ideal cardiovascular health. The Paris Prospective Study III. Sci Rep (2016) 0.75
Favorable Cardiovascular Health, Compression of Morbidity, and Healthcare Costs: Forty-Year Follow-Up of the CHA Study (Chicago Heart Association Detection Project in Industry). Circulation (2017) 0.75
Obesity-Related Hypertension in Children. Front Pediatr (2017) 0.75
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med (2010) 21.49
Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc (2007) 20.11
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med (2015) 19.14
Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation (2007) 18.32
Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med (2010) 16.40
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 14.72
American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc (2011) 14.42
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Evidence based physical activity for school-age youth. J Pediatr (2005) 13.50
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2009) 12.34
Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol (2007) 9.62
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2010) 9.18
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med (2011) 8.14
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med (2011) 7.16
Decline in physical activity in black girls and white girls during adolescence. N Engl J Med (2002) 7.06
Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation (2005) 7.04
Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension (2008) 6.96
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Lipid screening and cardiovascular health in childhood. Pediatrics (2008) 6.62
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation (2011) 6.36
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA (2012) 6.29
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet (2014) 6.23
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil (2007) 6.10
Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension (2006) 5.59
Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA (2012) 5.27
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation (2008) 5.26
The prognostic value of a nomogram for exercise capacity in women. N Engl J Med (2005) 5.03
Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics (2004) 5.01
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med (2010) 4.87
Relation between the changes in physical activity and body-mass index during adolescence: a multicentre longitudinal study. Lancet (2005) 4.65
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc (2004) 4.48
ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2012) 4.45
Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation (2003) 4.19
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care (2010) 4.10
Guidelines for lipid screening in children and adolescents: bringing evidence to the debate. Pediatrics (2012) 3.98
A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab (2003) 3.93
Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation (2010) 3.83
The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med (2004) 3.78
Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation (2010) 3.63
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA (2004) 3.48
Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation (2012) 3.39
Trends in prehospital delay time and use of emergency medical services for acute myocardial infarction: experience in 4 US communities from 1987-2000. Am Heart J (2005) 3.32